Furthermore, blocking IL-6 reduced invasive outgrowths from the DCIS-CAF structures (Fig. 7d), effects similar to those observed in the presence of MEPs (Fig. 3b). The gene discussed is IL6; the disease is ductal breast carcinoma in situ.